Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy

Journal of Vascular Surgery

Volumn 51, Issue 5 SUPPL., 2010, Pages 5S-17S

  Bradbury, Andrew W ^a   Adam, Donald J ^a   Bell, Jocelyn ^a   Forbes, John F ^b   Fowkes, F Gerry R ^b   Gillespie, Ian ^b   Ruckley, Charles Vaughan ^b   Raab, Gillian M ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c EDINBURGH NAPIER UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LEG AMPUTATION; LEG REVASCULARIZATION; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SURGICAL RISK; SURVIVAL TIME;

EID: 77951546951     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.01.073     Document Type: Article

References (103)

1. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G., and TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 33 suppl 1 (2007) S1-S75
2. Axisa B., Fishwick G., Bolia A., Thompson M.M., London N.J., Bell P.R., and Naylor A.R. Complications following peripheral angioplasty. Ann R Coll Surg Engl 84 (2002) 39-42
3. Shaw M.B., DeNunzio M., Hinwood D., Nash R., Callum K.G., and Braithwaite B.D. The results of subintimal angioplasty in a district general hospital. Eur J Vasc Endovasc Surg 24 (2002) 524-527
4. Loftus I.M., Hayes P.D., and Bell P.R. Subintimal angioplasty in lower limb ischaemia. J Cardiovasc Surg 45 (2004) 217-229
5. Jamsen T., Tulla H., Manninen H., Raisanen H., Lahtinen S., Aittola V., et al. Results of infrainguinal bypass surgery: an analysis of 263 consecutive operations. Ann Chir Gynaecol 90 (2001) 92-99
6. Dougherty M.J., Young L.P., and Calligaro K.D. One hundred twenty-five concomitant endovascular and open procedures for lower extremity arterial disease. J Vasc Surg 37 (2003) 316-322
7. Nguyen L.L., Conte M.S., Menard M.T., Gravereaux E.C., Chew D.K., Donaldson M.C., et al. Infrainguinal vein bypass graft revision: factors affecting long-term outcome. J Vasc Surg 40 (2004) 916-923
8. Morgan III J.H., Wall Jr. C.E., Christie D.B., Harvey R.L., and Solis M.M. The results of superficial femoral, popliteal, and tibial artery stenting for peripheral vascular occlusive disease. Am Surg 71 (2005) 905-909
9. Abdul Raouf A., Rouleau Y., Clement A., Le Roux P., Genay P., and Ricco J.B. Endoluminal angioplasty of the popliteal artery. Review of 54 consecutive patients. Eur J Vasc Endovasc Surg 30 (2005) 610-613
10. Smith B.M., Stechman M., Gibson M., Torrie E.P., Magee T.R., and Galland R.B. Subintimal angioplasty for superficial femoral artery occlusion: poor patency in critical ischaemia. Ann R Coll Surg Engl 87 (2005) 361-365
11. Bolia A. Subintimal angioplasty in lower limb ischaemia. J Cardiovasc Surg 46 (2005) 385-394
12. Nowygrod R., Egorova N., Greco G., Anderson P., Gelijns A., Moskowitz A., et al. Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg 43 (2006) 205-216
13. Vraux H., and Bertoncello N. Subintimal angioplasty of tibial vessel occlusions in critical limb ischaemia: a good opportunity?. Eur J Vasc Endovasc Surg 32 (2006) 663-667
14. Awad S., Karkos C.D., Serrachino-Inglott F., Cooper N.J., Butterfield J.S., Ashleigh R., et al. The impact of diabetes on current revascularisation practice and clinical outcome in patients with critical lower limb ischaemia. Eur J Vasc Endovasc Surg 32 (2006) 51-59
15. Conte M.S., Bandyk D.F., Clowes A.W., Moneta G.L., Seely L., Lorenz T.J., et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 43 (2006) 742-751
16. Lu X.W., Idu M.M., Ubbink D.T., and Legemate D.A. Meta-analysis of the clinical effectiveness of venous arterialization for salvage of critically ischaemic limbs. Eur J Vasc Endovasc Surg 31 (2006) 493-499
17. Bosiers M., Hart J.P., Deloose K., Verbist J., and Peeters P. Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures. Vascular 14 (2006) 63-69
18. Kudo T., Chandra F.A., Kwun W.H., Haas B.T., and Ahn S.S. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery. J Vasc Surg 44 (2006) 304-313
19. Engelhardt M., Bruijnen H., Scharmer C., Jezdinsky N., and Wolfle K. Improvement of quality of life six months after infrageniculate bypass surgery: diabetic patients benefit less than non-diabetic patients. Eur J Vasc Endovasc Surg 32 (2006) 182-187
20. Taylor S.M., Cull D.L., Kalbaugh C.A., Cass A.L., Harmon S.A., Langan III E.M., et al. Critical analysis of clinical success after surgical bypass for lower-extremity ischemic tissue loss using a standardized definition combining multiple parameters: a new paradigm of outcomes assessment. J Am Coll Surg 204 (2007) 831-838
21. Eskelinen E., and Lepantalo M. Role of infrainguinal angioplasty in the treatment of critical limb ischaemia. Scan J Surg 96 (2007) 11-16
22. Lepantalo M., and Eskelinen E. Outcome of infrapopliteal bypass in the elderly. Acta Chir Bel 107 (2007) 1-7
23. Graziani L., Silvestro A., Bertone V., Manara E., Alicandri A., Parrinello G., et al. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease. Nephrol Dial Transplant 22 (2007) 1144-1149
24. Bargellini I., Petruzzi P., Scatena A., Cioni R., Cicorelli A., Vignali C., et al. Primary infrainguinal subintimal angioplasty in diabetic patients. Cardiovasc Intervent Radiol 31 (2008) 713-722
25. Lantis J., Jensen M., Benvenisty A., Mendes D., Gendics C., and Todd G. Outcomes of combined superficial femoral endovascular revascularization and popliteal to distal bypass for patients with tissue loss. Ann Vasc Surg 22 (2008) 366-371
26. Malmstedt J., Leander K., Wahlberg E., Karlstrom L., Alfredsson L., and Swedenborg J. Outcome after leg bypass surgery for critical limb ischemia is poor in patients with diabetes: a population-based cohort study. Diabetes Care 31 (2008) 887-892
27. Habib S.B., Sonoda L., See T.C., Ell P.J., and Groves A.M. How do patients perceive the benefits and risks of peripheral angioplasty?. Implications for informed consent. J Vasc Intervent Radiol 19 (2008) 177-181
28. Nguyen L.L., Hevelone N., Rogers S.O., Bandyk D.F., Clowes A.W., Moneta G.L., et al. Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss. Circulation 119 (2009) 123-130
29. Mahmud E., Cavendish J.J., and Salami A. Current treatment of peripheral arterial disease: role of percutaneous interventional therapies. J Am Coll Cardiol 50 (2007) 473-490
30. Tang G.L., and Morasch M.D. Role of stents, drug-eluting stents, and stent-grafts in treatment of infrainguinal arterial disease. Semin Vasc Surg 20 (2007) 37-41
31. Rogers J.H., and Laird J.R. Overview of new technologies for lower extremity revascularization. Circulation 116 (2007) 2072-2085
32. Met R., Van Lienden K.P., Koelemay M.J., Bipat S., Legemate D.A., and Reekers J.A. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review. Cardiovasc Intervent Radiol 31 (2008) 687-697
33. Bradbury A.W., Bell J., Lee A.J., Prescott R.J., Gillespie I., Stansby G., et al. Bypass or angioplasty for severe limb ischaemia?. A Delphi Consensus Study. Eur J Vasc Endovasc Surg 24 (2002) 411-416
34. Bradbury A., Wilmink T., Lee A.J., Bell J., Prescott R., Gillespie I., et al. Bypass versus angioplasty to treat severe limb ischemia: factors that affect treatment preferences of UK surgeons and interventional radiologists. J Vasc Surg 39 (2004) 1026-1032
35. Adam D.J., Beard J.D., Cleveland T., Bell J., Bradbury A.W., Forbes J.F., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366 (2005) 1925-1934
36. Second European consensus document on chronic critical leg ischemia. Circulation 84 suppl 4 (1991) 1-26
37. Bradbury A.W., Adam D.J., Bell J., Forbes J.F., Fowkes F.G.R., Gillespie I., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg 51 Suppl 10 (2010) 18S-31S
38. Bollinger A., Breddin K., Hess H., Heystraten F.M., Kollath J., Konttila A., et al. Semi-quantitative assessment of lower limb atherosclerosis from routine angiographic images. Atherosclerosis 38 (1981) 339-346
39. Bradbury A.W., Adam D.J., Bell J., Forbes J.F., Fowkes F.G.R., Gillespie I., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classification. J Vasc Surg 51 Suppl 10 (2010) 32S-42S
40. Forbes J.F., Adam D.J., Bell J., Fowkes F.G.R., Gillespie I., Raab G.M., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis. J Vasc Surg 51 Suppl 10 (2010) 43S-51S
41. Karrison T. Restricted mean life with adjustment for covariates. J Am Stat Assoc 82 (1987) 1169-1176
42. Desai T.R., Meyerson S.L., Skelly C.L., MacKenzie K.S., Bassiouny H.S., Katz D., et al. Patency and limb salvage after infrainguinal bypass with severely compromised ("blind") outflow. Arch Surg 13 (2001) 635-642
43. Al-Omran M., Tu J.V., Johnston K.W., Mamdani M.M., and Kucey D.S. Outcome of revascularization procedures for peripheral arterial occlusive disease in Ontario between 1991 and 1998: a population-based study. J Vasc Surg 38 (2003) 279-288
44. Atar E., Siegel Y., Avrahami R., Bartal G., Bachar G.N., and Belenky A. Balloon angioplasty of popliteal and crural arteries in elderly with critical chronic limb ischemia. Eur J Radiol 53 (2005) 287-292
45. Abando A., Akopian G., and Katz S.G. Patient sex and success of peripheral percutaneous transluminal arterial angioplasty. Arch Surg 140 (2005) 757-761
46. DeRubertis B.G., Faries P.L., McKinsey J.F., Chaer R.A., Pierce M., Karwowski J., et al. Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions. Ann Surg 246 (2007) 415-422
47. Lipsitz E.C., Ohki T., Veith F.J., Suggs W.D., Wain R.A., Cynamon J., et al. Does subintimal angioplasty have a role in the treatment of severe lower extremity ischemia?. J Vasc Surg 37 (2003) 386-391
48. Tefera G., Turnipseed W., and Tanke T. Limb salvage angioplasty in poor surgical candidates. Vasc Endovasc Surg 37 (2003) 99-104
49. DeRubertis B.G., Pierce M., Ryer E.J., Trocciola S., Kent K.C., and Faries P.L. Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg 47 (2008) 101-108
50. Ishii H., Kumada Y., Toriyama T., Aoyama T., Takahashi H., Yamada S., et al. Cilostazol improves long-term patency after percutaneous transluminal angioplasty in hemodialysis patients with peripheral artery disease. Clin J Am Soc Nephrol 3 (2008) 1034-1040
51. Werk M., Langner S., Reinkensmeier B., Boettcher H.F., Tepe G., Dietz U., et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 118 (2008) 1358-1365
52. Perera G.B., and Lyden S.P. Current trends in lower extremity revascularization. Surg Clin North Am 87 (2007) 1135-1147
53. Zeller T. Current state of endovascular treatment of femoro-popliteal artery disease. Vascular Medicine 12 (2007) 223-234
54. White C.J., and Gray W.A. Endovascular therapies for peripheral arterial disease: an evidence-based review. Circulation 116 (2007) 2203-2215
55. Lee L.K., and Kent K.C. Infrainguinal occlusive disease: endovascular intervention is the first line therapy. Advance Surg 42 (2008) 193-204
56. Bradbury A.W., Adam D.J., Bell J., Forbes J.F., Fowkes F.G.R., Gillespie I., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making. J Vasc Surg 51 Suppl 10 (2010) 52S-68S
57. Khan S., Flather M., Mister R., Delahunty N., Fowkes G., Bradbury A., et al. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry. Eur J Vasc Endovasc Surg 33 (2007) 442-450
58. Schanzer A., Hevelone N., Owens C.D., Beckman J.A., Belkin M., and Conte M.S. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. J Vasc Surg 47 (2008) 774-778
59. Feringa H.H., Bax J.J., Hoeks S., van Waning V.H., Elhendy A., Karagiannis S., et al. A prognostic risk index for long-term mortality in patients with peripheral arterial disease. Arch Intern Med 167 (2007) 2482-2489
60. Aung P.P., Maxwell H.G., Jepson R.G., Price J.F., and Leng G.C. Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev (2007) CD000123
61. Feringa H.H., Karagiannis S.E., van Waning V.H., Boersma E., Schouten O., Bax J.J., et al. The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease. J Vasc Surg 45 (2007) 936-943
62. Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg 45 (2007) 645-654
63. Collins T.C., Souchek J., and Beyth R.J. Benefits of antithrombotic therapy after infrainguinal bypass grafting: a meta-analysis. Am J Med 117 (2004) 93-99
64. Carter A., Murphy M.O., Halka A.T., Turner N.J., Kirton J.P., Murray D., et al. The natural history of stenoses within lower limb arterial bypass grafts using a graft surveillance program. Ann Vasc Surg 21 (2007) 695-703
65. Welten G.M., Schouten O., Hoeks S.E., Chonchol M., Vidakovic R., van Domburg R.T., et al. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. J Am Coll Cardiol 51 (2008) 1588-1596
66. Owens C.D., Ho K.J., and Conte M.S. Lower extremity vein graft failure: a translational approach. Vasc Med 13 (2008) 63-74
67. Conte M.S., Lorenz T.J., Bandyk D.F., Clowes A.W., Moneta G.L., and Seely B.L. Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc Endovasc Surg 39 (2005) 15-23
68. Feinglass J., Pearce W.H., Martin G.J., Gibbs J., Cowper D., Sorensen M., et al. Postoperative and amputation-free survival outcomes after femorodistal bypass grafting surgery: findings from the Department of Veterans Affairs National Surgical Quality Improvement Program. J Vasc Surg 34 (2001) 283-290
69. Faries P.L., Arora S., Pomposelli Jr. F.B., Pulling M.C., Smakowski P., Rohan D.I., et al. The use of arm vein in lower-extremity revascularization: results of 520 procedures performed in eight years. J Vasc Surg 31 (2000) 50-59
70. Landry G.J., Moneta G.L., Taylor Jr. L.M., Edwards J.M., Yeager R.A., and Porter J.M. Long-term outcome of revised lower-extremity bypass grafts. J Vasc Surg 35 (2002) 56-62
71. Landry G.J., Liem T.K., Mitchell E.L., Edwards J.M., and Moneta G.L. Factors affecting symptomatic vs. asymptomatic vein graft stenoses in lower extremity bypass grafts. Arch Surg 142 (2007) 848-853
72. Davies A.H., Hawdon A.J., Sydes M.R., Thompson S.G., and VGST Participants. Is duplex surveillance of value after leg vein bypass grafting?. Principal Results of the Vein Graft Surveillance Randomised Trial (VGST). Circulation 112 (2005) 1985-1991
73. Kasapis C., Henke P.K., Chetcuti S.J., Koenig G.C., Rectenwald J.E., Krishnamurthy V.N., Grossman P.M., and Gurm H.S. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J 30 (2009) 44-55
74. Bosiers M., Cagiannos C., Deloose K., Verbist J., and Peeters P. Drug-eluting stents in the management of peripheral arterial disease. Vasc Health Risk Manage 4 (2008) 553-559
75. Koppensteiner R., Spring S., Amann-Vesti B.R., Meier T., Pfammatter T., Rousson V., Banyai M., and van der Loo B. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial. J Vasc Surg 44 (2006) 1247-1253
76. Schindler C., Mueller A., Bramlage P., Boecking W., Kirch W., and Schweizer J. Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study. Angiology 58 (2008) 710-716
77. Jacobs D.L., Motaganahalli R.L., Cox D.E., Wittgen C.M., and Peterson G.J. True lumen re-entry devices facilitate subintimal angioplasty and stenting of total chronic occlusions: initial report. J Vasc Surg 43 (2006) 1291-1296
78. Zeller T., Tiefenbacher C., Steinkamp H.J., Langhoff R., Wittenberg G., Schluter M., Buergelin K., Rastan A., Krumsdorf U., Sixt S., Schulte C.L., Tubler T., and Krankenberg H. Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT). J Endovasc Ther 15 (2008) 390-398
79. Krankenberg H., Schluter M., Steinkamp H.J., Burgelin K., Scheinert D., Schulte K.L., et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 116 (2007) 285-292
80. Schillinger M., Sabeti S., Loewe C., Dick P., Amighi J., Mlekusch W., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006) 1879-1888
81. Schmehl J., and Tepe G. Current status of bare and drug-eluting stents in infrainguinal peripheral vascular disease. Expert Rev Cardiovasc Ther 6 (2008) 531-538
82. Tan J.W., Yeo K.K., and Laird J.R. Excimer laser assisted angioplasty for complex infrainguinal peripheral artery disease: a 2008 update. J Cardiovasc Surg 49 (2008) 329-340
83. Rocha-Singh K.J., Jaff M.R., Crabtree T.R., Bloch D.A., Ansel G., VIVA Physicians, and Inc. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Cathete Cardiovasc Inter 69 (2007) 910-919
84. Diehm N., Baumgartner I., Jaff M., Do D.D., Minar E., Schmidli J., et al. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. Eur Heart J 28 (2007) 798-805
85. Weinberger J., Rundback J.H., and Ratchford E.V. Regulatory approval of peripheral endovascular revascularization devices in the United States: is the horse still in the barn?. Am J Therapeut 12 (2005) 186-191
86. Diehm N., Diehm C., Kalka C., and Dick F. Peripheral endovascular revascularization trials: high noon for uniform reporting standards. Acta Chir Bel 108 (2008) 382-385
87. Diehm N., Pattynama P.M., Jaff M.R., Cremonesi A., Becker G.J., Hopkins L.N., et al. Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions. Eur J Vasc Endovasc Surg 36 (2008) 409-419
88. Goshima K.R., Mills Sr. J.L., and Hughes J.D. A new look at outcomes after infrainguinal bypass surgery: traditional reporting standards systematically underestimate the expenditure of effort required to attain limb salvage. J Vasc Surg 39 (2004) 330-335
89. Caruana M.F., Bradbury A.W., and Adam D. The validity, reliability, reproducibility and extended utility of ankle to brachial pressure index in current vascular surgical practice. Eur J Vasc Endovasc Surg 29 (2005) 443-451
90. Wolfe J.H., and Wyatt M.G. Critical and subcritical ischaemia. Eur J Vasc Endovasc Surg 13 (1997) 578-582
91. White J.V., Rutherford R.B., and Ryjewski C. Chronic subcritical limb ischemia: a poorly recognized stage of critical limb ischemia. Semin Vasc Surg 20 (2007) 62-67
92. Brass E.P., Anthony R., Dormandy J., Hiatt W.R., Jiao J., Nakanishi A., et al., Circulase investigators. Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg 43 (2006) 752-759
93. Nehler M.R., Brass E.P., Anthony R., Dormandy J., Jiao J., McNamara T.O., et al. Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes. J Vasc Surg 45 (2007) 953-961
94. Marston W.A., Davies S.W., Armstrong B., Farber M.A., Mendes R.C., Fulton J.J., et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg 44 (2006) 108-114
95. Nehler M.R., and Peyton B.D. Is revascularization and limb salvage always the treatment for critical limb ischemia?. J Cardiovasc Surg 45 (2004) 177-184
96. Reed A.B., Delvecchio C., and Giglia J.S. Major lower extremity amputation after multiple revascularizations: was it worth it?. Ann Vasc Surg 22 (2008) 335-340
97. Chung J., Bartelson B.B., Hiatt W.R., Peyton B.D., McLafferty R.B., Hopley C.W., et al. Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemia. J Vasc Surg 43 (2006) 1183-1190
98. Taylor S.M. Current status of heroic limb salvage for critical limb ischemia. Am Surg 74 (2008) 275-284
99. Novo S., Coppola G., and Milio G. Critical limb ischemia: definition and natural history. Current Drug Targets Cardiovas Haematol Disord 4 (2004) 219-225
100. McCaslin J.E., Hafez H.M., and Stansby G. Lower-limb revascularization and major amputation rates in England. Br J Surg 94 (2007) 835-839
101. Cao P., and De Rango P. Endovascular treatment of peripheral arterial disease: so lld yet so far from evidence!. Eur J Vasc Endovasc Surg 37 (2009) 501-503
102. Conte M.S., Geraghty P.J., Bradbury A.W., Hevelone N.D., Lipsitz S.R., Moneta G.L., et al. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg 50 (2009) 1462-1473
103. Geraghty P.J., Matsumura J.S., and Conte M.S. Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals. J Vasc Surg 50 (2009) 1459-1461